CM/TNS/24/5711 -NHS Framework for the supply of Ustekinumab
Who
| Buyer | NHS England — not a council we hold |
| Supplier | Accord-UK Ltd |
| Supplier | Amgen Ltd |
| Supplier | Celltrion Healthcare United Kingdom Limited |
| Supplier | Janssen-Cilag Ltd |
| Supplier | Sandoz Ltd |
| Supplier | Thornton and Ross Ltd |
What
Project title: NHS National Framework for the supply of Ustekinumab 1 September 2024 Offer reference number: CM/TNS/24/5711 CM/TNS/24/5711/01 - NHS Framework for the supply of Ustekinumab - London & South of England. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/TNS/24/5711/02 - NHS Framework for the supply of Ustekinumab - North of England and Midlands & East. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Dates and source
| Runs | 1 Sep 2024 to 31 Aug 2026 |
| OCID | ocds-b5fd17-bd18e8bf-f1dd-455f-8b23-688c3cad9f30 |
| Notice | Read it on Contracts Finder |
Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.